SYRE
#989
Spyre Therapeutics, Inc. - Common Stock
102.0 7 USD
+0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+3.15%
Monthly Change
+21.61%
6 month change
+213.68%
Year Change
+326.89%
Previous Close
98.9 5
Open
102.0 7
Low
102.0 7
High
102.0 7
Volume
177
Financials
- Market Capitalization 8.86 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-23.79
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 975 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 75.82 USD | +1.03% | -5.74% | +8.87% | +13.50% | 8.99 B USD | ||
| 987 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 318.42 USD | -2.83% | -4.11% | +22.90% | +477.89% | 8.88 B USD | ||
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.90 USD | +0.23% | +0.47% | +139.71% | +104.14% | 8.85 B USD | ||
| 997 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 135.46 USD | +3.19% | -2.73% | +22.21% | +80.30% | 8.71 B USD |
Frequently asked questions about Spyre Therapeutics, Inc. - Common Stock
What is the Spyre Therapeutics, Inc. - Common Stock stock price today?
The current price of Spyre Therapeutics, Inc. - Common Stock (SYRE) is 102.07. Over the past 24 hours, the stock has changed by +3.15%. Follow the SYRE chart for real-time price dynamics.
What is the stock ticker of Spyre Therapeutics, Inc. - Common Stock?
Spyre Therapeutics, Inc. - Common Stock trades under the ticker SYRE. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Spyre Therapeutics, Inc. - Common Stock stock going up?
SYRE has changed by +5.48% over the last week, +21.61% over the last month, and +326.89% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Spyre Therapeutics, Inc. - Common Stock net income for the last quarter?
Spyre Therapeutics, Inc. - Common Stock reported net income of -69 M for the last quarter. The previous quarter showed -62.53 M, which means net income changed by -10.36%.
How many employees does Spyre Therapeutics, Inc. - Common Stock have?
As of the latest available data, Spyre Therapeutics, Inc. - Common Stock has 112 employees. Workforce size can provide additional context about the company's scale and operations.
What is Spyre Therapeutics, Inc. - Common Stock EBITDA?
Spyre Therapeutics, Inc. - Common Stock EBITDA is -77.97 M, and its EBITDA margin is 257.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Spyre Therapeutics, Inc. - Common Stock stock?
You can buy Spyre Therapeutics, Inc. - Common Stock (SYRE) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Spyre Therapeutics, Inc. - Common Stock stock?
Investing in Spyre Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SYRE chart and related analysis on metatrader.com as part of your research.